Tovuudorj Avirmed

Prof. Dr. Tovuudorj Avirmed

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2024 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
BEBattamir Enkhtuya
Battamir Enkhtuya
ABAmgalan Bayarsaikhan
Amgalan Bayarsaikhan
BLBattuvshin Lkhagvasuren
Battuvshin Lkhagvasuren
USUranbileg Sainbat
Uranbileg Sainbat
BBBinderiya Bayanmunkh
Binderiya Bayanmunkh
BTBayarmaa Tsend
Bayarmaa Tsend
Epilepsy is a prevalent neurological disorder in the pediatric population, often accompanied by comorbidities, drug-related burdens, and psychosocial issues. Emotional intelligence (EI) is a crucial aspect of neurocognitive functioning that may be impaired in various clinical conditions. This study aimed to assess EI and its associated risk factors in children with epilepsy. In a case-control design, we recruited 47 children with epilepsy (37 males, mean age 10.5 ± 3.1 years) and age- and gender-matched controls. Participants were evaluated using the Emotional Quotient Inventory: Youth Version (EQ-I:YV). We included risk factors, including comorbidities, perinatal complications, epilepsy characteristics, and magnetic resonance imaging results to predict EI. Results indicate that children with epilepsy demonstrated significantly lower EI scores compared to controls (Total EQ score: p = 0.031, intrapersonal: p < 0.001, adaptability: p = 0.03, and general mood: p < 0.001). Multiple linear regression analysis indicated that lower total EQ scores were associated with the number of anti-epileptic drugs, age, seizure frequency, MRI abnormalities, aura, and early onset of seizures. The study provides evidence that children with epilepsy exhibit lower EQ scores than control group, with notable differences in intrapersonal skills, adaptability, and general mood. Additionally, age, and some seizure-related factors predicted decreased total EQ scores. These findings emphasize the need to consider EI in the context of pediatric epilepsy, as impaired EI may contribute to further psychosocial challenges faced by affected children.

Verified
Journal Article
Open access
PDF file
USUlziizaya Sodov
Ulziizaya Sodov
KZKhishigsuren Zuunnast
Khishigsuren Zuunnast
HSHerrmann Stefan
Herrmann Stefan
TATovuudorj Avirmed
Tovuudorj Avirmed
Introduction: Epilepsy is a chronic neurological disorder, with cognitive impairment being one of its most significant comorbidities. While the majority of individuals with epilepsy maintain regular intellectual abilities, they are more likely to experience cognitive impairment compared to a healthy control group of the same age and educational level. Aim: This study aimed to assess cognitive impairment during epilepsy, particularly temporal lobe epilepsy, and to evaluate the effectiveness of using the Montreal Cognitive Assessment (MoCA) test for cognitive screening in individuals with epilepsy. Materials and methods: One hundred and fifty subjects were included between 2022 and 2023, which were divided into 50 people diagnosed with temporal lobe epilepsy (TLE), 50 people with other types of epilepsy according to the International League Against Epilepsy (ILAE), and 50 healthy controls without epilepsy (HC). Results: Significant differences were found in the total mean scores of the MoCA between TLE, other types of epilepsy, and healthy control groups (p = 0.000), particularly in visuospatial orientation, concentration, memory recall, abstraction, and language skills. Conclusions: Evaluating cognitive impairment in epilepsy involves comprehensive neuropsychological assessments, which have significantly advanced in recent years. Nevertheless, we consider the Montreal Cognitive Assessment (MoCA) test to be an appropriate initial screening tool for assessing cognitive impairment in epilepsy.